Active · per the CBE, 29 October 2026

Firas

BE0740734362

Rechtspersoon Private limited company 1 establishment

Gaverstraat 39, 8780 Oostrozebeke

Behind the company: Thomas MALFAIT.

Active for

6 year, 9 months

Financials

Financial year 2025

Firas from Oostrozebeke, company number BE0740734362, closed financial year 2025 with a result of € 440,170 after tax. For that financial year Firas recorded a gross margin of € 603,098 and equity of € 38,786. Compared with financial year 2024, the result moved from € 450,162 to € 440,170. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.

What it is worth Healthy

€ 38,786

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 440,170

▼ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 120,410

▼ 27% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 440,170 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 65,002

▼ 23% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes and wages

€ 12,200

▼ 38% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 405,061 € 563,070 € 616,722 € 603,098 ▼ 2%
Profit after taxes € 308,086 € 422,709 € 450,162 € 440,170 ▼ 2%
Equity € 606,077 € 38,786 € 38,786 € 38,786
Total debts € 42,415 € 509,730 € 470,515 € 410,815 ▼ 13%
Cash € 396,441 € 168,393 € 165,629 € 120,410 ▼ 27%
Retained profit € 601,077 € 33,786 € 33,786 € 33,786
Dividend € 0 € 990,000 € 450,162 € 440,170 ▼ 2%
Balance sheet total € 648,492 € 548,516 € 509,301 € 449,601 ▼ 12%

Key figures of Firas, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Firas?

What happened at Firas in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 440,170 (▼ 2% vs 2024). Source: NBB ↗
  • New establishment in Oostrozebeke. KBO
  • Start of the company according to the CBE. KBO

In short

From € 308,086 profit in 2022 to € 440,170 profit in 2025.

Paid € 517,107 in corporate taxes since 2022.

Best year ever: 2024, with € 450,162 profit.

Paid out € 1.9 million in dividends to the owners in total.

Management

Thomas MALFAIT
Firas

Behind Firas is Thomas MALFAIT. It owns 16.7% of NEFROLOGIE AZ DELTA itself.

Directors

According to the 2025 annual accounts

Thomas MALFAIT

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Gaverstraat 39

8780 Oostrozebeke

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0740.734.362
VAT number
BE 0740.734.362
Registered office
Gaverstraat 39, 8780 Oostrozebeke
Names & denominations
Firas
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
4 January 2020
Peppol
Active · Active since 22 Jul 2026

Frequently asked questions

What is the address of Firas?
The registered office of Firas is located at Gaverstraat 39, 8780 Oostrozebeke.
Is Firas still active?
Yes. According to the CBE (29 October 2026) Firas is active, legal situation “Normale toestand”, started on 4 January 2020.
Is Firas registered on Peppol?
Yes, Firas is registered on the Peppol network with ID 0208:0740734362.
What is the enterprise number of Firas?
The enterprise number of Firas is BE0740734362.
When was Firas founded?
Firas was founded on 4 January 2020.
Who owns Firas?
Behind Firas is Thomas MALFAIT. It owns 16.7% of NEFROLOGIE AZ DELTA itself.